ODDITY LABS announces intention to distribute for share repurchases
The Board approved a $200M repurchase plan amendment, with $86.9M remaining for distribution, meeting solvency test.
See the latest news and media coverage for ODDITY LABS. We track all announcements, press releases, and industry mentions in real time, all in one place.
AI-driven molecular discovery lab
odditylabs.aiLast updated
In short: ODDITY LABS reported a significant Q1 2026 revenue decline and a $21.4 million net loss, but authorized a $200 million share repurchase.
The Board approved a $200M repurchase plan amendment, with $86.9M remaining for distribution, meeting solvency test.
Net loss of $21.4 million and adjusted EBITDA of $(7.0) million as CPA dislocation impacts results.
The Board approved repurchasing up to $200 million in Class A shares, replacing the prior $150 million plan. It expires March 31, 2029 or upon full deployment.
Full-year net revenue reaches $810 million, up 25% YoY. Q4 revenue hits $153 million with adjusted EBITDA of $13 million. Exceeded guidance; launched METHODIQ brand.
While we did not build our business on favorable user acquisition cost, rather on strong over 100% 12-month repeat rate,...
ODDITY Tech Ltd. ("ODDITY") (NASDAQ: ODD), today announced that it will release its first quarter 2026 financial results before the market open on Tuesday, June...
Investing.com - Goldman Sachs lowered its price target on Oddity Tech Ltd (NASDAQ:ODD) to $16 from $20 while maintaining a Neutral rating on the stock...
On February 25, 2026, Oddity released its fourth quarter and full year 2025 financial results, disclosing that the Company "experienced a dislocation in [its] account...
Track ODDITY LABS and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.